<DOC>
	<DOCNO>NCT00195156</DOCNO>
	<brief_summary>The purpose study find high tolerate dose Depakote combination liposome encapsulate all-trans retinoic acid ( ATRA-IV ) patient advance solid tumor malignancy .</brief_summary>
	<brief_title>Treatment With ATRA-IV Depakote Patients With Advanced Solid Tumor Malignancies</brief_title>
	<detailed_description>To determine maximum tolerate dose Depakote combination liposome encapsulate all-trans retinoic acid ( ATRA-IV ) patient advance solid tumor malignancy . This 2-step dose escalation study . Once patient start therapy designate dose level , escalate patient . Three patient dose level must complete 4 week therapy escalate next high level . If none patient experience dose limit toxicity ( DLT ) , 3 new patient treat next high dose level .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Patients histologic confirmation solid tumor malignancy clinical evidence metastatic disease . Patients must fail least one standard therapy , available , malignancy . Patients may enter trial without prior therapy standard effective therapy available . No active brain metastasis epidural tumor . Concomitant administration steroid . Irradiation chemotherapy within 14 day start protocol . Evidence another active cancer , except nonmelanoma , carcinoma skin insitu carcinoma cervix curatively treat , Stage I II cancer patient currently complete remission , cancer patient disease free great 5 year . Women pregnant lactating . Women men reproductive age unwilling use two form effective contraception . Patients clinically significant cardiac , renal hepatic disease ; severe debilitate pulmonary disease ; history diabetes mellitus prone ketoacidosis . Patients history pancreatitis . Patients know hypersensitivity retinoids retinoic acid derivative . Patients coagulation disorder , thrombophlebitis pulmonary embolism . Patients preexist psychiatric condition , especially depression history severe uncontrolled psychiatric disorder . Patients preexist thyroid abnormality whose thyroid function maintain normal range . Patients chronic moderate severe nausea . Patients history epilepsy seizure disorder take anticonvulsant medication .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Solid Tumor Malignancies</keyword>
</DOC>